Le Lézard
Classified in: Health
Subject: SVY

Growth Opportunities in the Global Wearable Medical Device Market


NEW YORK, Oct. 17, 2017 /PRNewswire/ --

The future of the global wearable medical device market looks promising with opportunities in home healthcare and remote patient monitoring.



Read the full report: https://www.reportlinker.com/p05147462



The global wearable medical device market is expected to reach an estimated $9.4 billion by 2022 and it is forecast to grow at a CAGR of 14.9% from 2017 to 2022. The major drivers of growth are increasing awareness and importance of fitness and healthy lifestyle, rising chronic diseases, and technological innovations.

Emerging trends, which have a direct impact on the dynamics of the global wearable medical device market, include the increasing usage of wearable biofeedback devices and increasing adoption of cloud technology for interconnected healthcare devices. Medtronic Plc, Roche Holding AG, and Animas Corporation (Johnson & Johnson) are the major manufacturers of the wearable medical device market.

Wearable Medical Device Market TrendsWearable Medical Device Market Forecast
Growth Opportunities for the Global Wearable Medical Device Market

The study includes a forecast for the growth opportunities in the global wearable medical device market by end use type, application, distribution channel and region, as follows:
Wearable medical device market by application [Value ($ million) from 2011 to 2022]: Diagnostic Vital Sign Monitoring Neuromodulation Fetal and Obstetric Therapeutic Pain Management Wearables Diabetic Rehabilitation RespiratoryWearable medical device market by end use market [Value $ million from 2011 to 2022]: Healthcare Remote Patient Monitoring Wearable medical device market by distribution channel [Value $ million from 2011 to 2022]: Pharmacy and Clinics Others and OnlineWearable medical device market by region [Value ($ million) and Volume (million units) from 2011 to 2022]: North America US Canada Mexico Europe United Kingdom Germany France Spain Italy Asia Pacific China Japan Australia S. Korea The Rest of the World Latin America Middle East
Wearable medical device companies profiled in this market report include Medtronic Plc, Roche Holding AG, and Animas Corporation (Johnson & Johnson).

In this market, diagnostic wearable and therapeutic wearable are the main segments by application type. On the basis of its comprehensive research, Lucintel forecasts that diagnostic wearable device is expected to show highest growth during the forecast period from 2017 to 2022.

North America is expected to remain the largest as well as the highest growth region due to high disposable income, rising chronic conditions and acceptance of technologically advanced products in this region.

Some of the features of "Growth Opportunities in the wearable medical device Market 2017-2022: Market Size, Market Share, and Forecast Analysis" include:
Market size estimates: wearable medical device market size estimation in terms of volume (M Units) and value ($M) shipment.
Trend and forecast analysis: wearable medical device market trend (2011-2016) and forecast (2017-2022) by regions, products and applications.
Segmentation analysis: wearable medical device market size by end use type, application, distribution channel in terms of value.
Regional analysis: wearable medical device market breakdown by region such as, North America, Europe, Asia Pacific and Rest of the World
Growth opportunities: Analysis on growth opportunities in different end use type, application, distribution, and region of wearable medical device market.
Strategic analysis: This includes M&A, new product development, competitive landscape, and expansion strategies of wearable medical device suppliers. Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:
Q. 1. What are some of the most promising, high-growth opportunities for the global wearable medical device market by end use (healthcare, remote patient monitoring), application (diagnostic and therapeutic), distribution channel (pharmacy/clinics, online, and others), and region (North America, Europe, APAC, and the Rest of the World)?
Q. 2. Which segments will grow at a faster pace and why?
Q. 3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and reasons behind them?
Q.7. What are some changing customer demands in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What are the strategic initiatives of key players for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material / product substitution?
Q.11. What M&A activity has occurred in the last 5 years?

Read the full report: https://www.reportlinker.com/p05147462

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

https://www.reportlinker.com


__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...

at 18:01
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...

at 17:48
On Wednesday, April 17, the San Joaquin Valley Health Fund (SJVHF) launched "Equity on the Road" a multi-city series of community town halls to deepen local understanding of state issues and to advocate for more resources in the San Joaquin Valley....



News published on and distributed by: